DPD. Chase Pectol

D. Chase Pectol

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


D. Chase Pectol has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Effects of Glutathione and Histidine on NO Release from a Dimeric Dinitrosyl Iron Complex (DNIC)

    by D. Chase Pectol, Sarosh Khan, Mahmoud Elsabahy, Karen L. Wooley, Soon-Mi Lim, Marcetta Y. Darensbourg

    Rates of NO release from synthetic dinitrosyl iron complexes (DNICs) are shown to be responsive to coordination environments about iron. The effect of biologically relevant cellular components, glutathione and histidine, on the rate of NO release from a dimeric, “Roussin’s Red Ester”, DNIC with bridging μ-S thioglucose ligands, SGlucRRE or [(μ-SGluc)Fe(NO)2]2 (SGluc = 1-thio-β-d-glucose tetraacetate), was investigated. From the Griess assay and X-band EPR data, decomposition of the product from the histidine-cleaved dimer, [(SGluc)(NHis)Fe(NO)2], generated Fe(III) and increased the NO release rate in aqueous media when compared to the intact SGlucRRE precursor. In contrast, increasing concentrations of exogenous glutathione generated the stable [(SGluc)(GS)Fe(NO)2]− anion and depressed the rate of NO release. Both of the cleaved, monomeric intermediates were characterized with ESI-MS, EPR, and FT-IR spectroscopies. On the basis of the Griess assay coupled with data from an intracellular fluorometric probe, both the monomeric DNICs and dimeric SGlucRRE diffuse into smooth muscle cells, chosen as appropriate archetypes of vascular relaxation, and release their NO payload. Ultimately, this work provides insight into tuning NO release beyond the design of DNICs, through the incubation with safe, accessible biological molecules.


  • Open Access

    Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells

    by Seung W. Ryu, Rose Stewart, D. Chase Pectol, Nicolette A. Ender, Oshadi Wimalarathne, Ji-Hoon Lee, Carlos P. Zanini, Antony Harvey, Jon M. Huibregtse, Peter Mueller, et al.

    The 70 kDa heat shock protein (HSP70) family of chaperones are the front line of protection from stress-induced misfolding and aggregation of polypeptides in most organisms and are responsible for promoting the stability, folding, and degradation of clients to maintain cellular protein homeostasis. Here, we demonstrate quantitative identification of HSP70 and 71 kDa heat shock cognate (HSC70) clients using a ubiquitin-mediated proximity tagging strategy and show that, despite their high degree of similarity, these enzymes have largely nonoverlapping specificities. Both proteins show a preference for association with newly synthesized polypeptides, but each responds differently to changes in the stoichiometry of proteins in obligate multi-subunit complexes. In addition, expression of an amyotrophic lateral sclerosis (ALS)-associated superoxide dismutase 1 (SOD1) mutant protein induces changes in HSP70 and HSC70 client association and aggregation toward polypeptides with predicted disorder, indicating that there are global effects from a single misfolded protein that extend to many clients within chaperone networks. Together these findings show that the ubiquitin-activated interaction trap (UBAIT) fusion system can efficiently isolate the complex interactome of HSP chaperone family proteins under normal and stress conditions.


  • Toward the Optimization of Dinitrosyl Iron Complexes as Therapeutics for Smooth Muscle Cells

    by D. Chase Pectol, Sarosh Khan, Rachel B. Chupik, Mahmoud Elsabahy, Karen L. Wooley, Marcetta Y. Darensbourg, Soon-Mi Lim

    In this study, dinitrosyl iron complexes (DNIC’s) are shown to deliver nitric oxide (NO) into the cytosol of vascular smooth muscle cells (SMC’s), which play a major role in vascular relaxation and contraction. Malfunction of SMC’s can lead to hypertension, asthma, and erectile dysfunction, among other disorders. For comparison of the five DNIC deriva-tives, the following protocols were examined: a) the Griess assay to detect nitrite (derived from NO conversion) in the absence and presence of SMC’s; b) the MTS assay for cell viability; c) an immunotoxicity assay to establish if DNIC’s stimulate immune response; and d) a fluorometric assay to detect intracellular NO from treatment with DNIC’s. Dimeric Roussin’s Red Ester, RRE-type {Fe(NO)2}9 complexes containing phenylthiolate bridges, [(µ-SPh)Fe(NO)2]2 or SPhRRE, were found to deliver NO with the lowest effect on cell toxicity (i.e., highest IC50). In contrast, the RRE-DNIC with the bio-compatible thioglucose moiety, [(µ-SGlu)Fe(NO)2]2 (SGlu = 1-thio-β-d-glucose tetraacetate) or SGluRRE, delivered a high-er concentration of NO to the cytosol of SMC’s with a tenfold decrease in IC50. Additionally, monomeric DNIC’s stabilized by a bulky N-heterocyclic carbene (NHC), namely 1,3-bis(2,4,6-trimethylphenyl)imidazolidene (IMes), were synthesized and yielded the DNIC complexes SGluNHC, [IMes(SGlu)Fe(NO)2], and SPhNHC, [IMes(SPh)Fe(NO)2]. These oxidized {Fe(NO)2}9 NHC DNIC’s have IC50’s of ~7 µM; however, the NHC-based complexes did not transfer nitric oxide into the SMC. Per contra, the reduced, mononuclear {Fe(NO)2}10 neocuproine-based DNIC, neoDNIC, depressed the viability of the SMC’s, as well as generated an increase of intracellular NO. Regardless of coordination environment or oxidation state, all DNIC’s showed a dinitrosyl iron unit (DNIU)-dependent increase in viability. This study demonstrates a structure func-tion relationship between DNIU coordination environment and the efficacy of the DNIC treatments.